Table 1. Spearman correlations of significant inter (A) and intra- tissue correlations in the first mice population.
| Males | Females | ||||||||||||||||||||||||
| CpG 1 | CpG 2 | Ave of both | CpG 1 | CpG 2 | Ave of both | ||||||||||||||||||||
| Site 1 | Site 2 | p | p (Cor) | Rho | p | p (Cor) | Rho | p | p (Cor) | Rho | p | p (Cor) | Rho | p | p (Cor) | Rho | p | p (Corr) | Rho | ||||||
| A) | BM-Aactin | Sp-Aactin | 7,59E−06 | 2,30E−02 | 0,60 | 8,16E−01 | 1 | 0,04 | 2,10E−02 | 1 | 0,39 | 3,56E−04 | 1 | 0,52 | 6,46E−01 | 1 | 0,11 | 3,79E−01 | 1 | 0,20 | |||||
| He-LIT1 | Mu-LIT1 | 1,12E−03 | 1 | −0,47 | 7,67E−01 | 1 | −0,04 | 7,11E−02 | 1 | −0,27 | 7,09E−06 | 2,14E−02 | −0,62 | 7,57E−01 | 1 | −0,05 | 5,81E−04 | 1 | −0,50 | ||||||
| Lu-SNRPN | SK-PEG3 | 1,39E−01 | 1 | −0,22 | 7,13E−01 | 1 | 0,17 | 3,76E−01 | 1 | 0,18 | 8,37E−06 | 2,53E−02 | 0,59 | 2,62E−01 | 1 | 0,26 | 1,27E−03 | 1 | 0,45 | ||||||
| B) | BM-IAP | BM-L1 | 1,70E−01 | 1 | 0,20 | 2,38E−03 | 1 | 0,44 | 2,79E−03 | 1 | 0,43 | 3,00E−11 | 9,07E−08 | 0,79 | 7,62E−06 | 2,31E−02 | 0,60 | 2,69E−08 | 8,44E−05 | 0,71 | |||||
| BM-LIT1 | BM-IAP | 1,64E−01 | 1 | 0,22 | 1,01E−01 | 1 | 0,26 | 4,08E−02 | 1 | 0,32 | 2,82E−01 | 1 | −0,16 | 1,75E−06 | 5,31E−03 | 0,64 | 2,88E−02 | 1 | 0,32 | ||||||
| BM-MYC | BM-L1 | 5,91E−05 | 1,79E−01 | 0,55 | 5,68E−04 | 1 | 0,48 | 6,78E−06 | 2,13E−02 | 0,60 | 6,71E−09 | 2,03E−05 | 0,73 | 4,27E−08 | 1,29E−04 | 0,70 | 1,27E−12 | 3,98E−09 | 0,83 | ||||||
| BM-MYC | BM-IAP | 7,65E−01 | 1 | 0,05 | 9,78E−03 | 1 | 0,38 | 7,92E−03 | 1 | 0,39 | 1,05E−07 | 3,18E−04 | 0,68 | 6,47E−06 | 1,96E−02 | 0,60 | 1,40E−08 | 4,39E−05 | 0,71 | ||||||
| Br-Aactin | Br-PEG3 | 1,19E−02 | 1 | 0,38 | 5,05E−04 | 1 | 0,51 | 1,20E−02 | 1 | 0,38 | 6,07E−02 | 1 | 0,29 | 1,48E−05 | 4,48E−02 | 0,65 | 2,24E−04 | 7,01E−01 | 0,58 | ||||||
| Br-PEG3 | Br-SNRPN | 3,83E−02 | 1 | 0,35 | 5,29E−03 | 1 | 0,61 | 1,50E−03 | 1 | 0,68 | 1,17E−06 | 3,53E−03 | 0,72 | 1,63E−01 | 1 | 0,39 | 5,12E−03 | 1 | 0,70 | ||||||
| He-MYC | He-LIT1 | 1,65E−05 | 5,00E−02 | 0,57 | 9,26E−06 | 2,80E−02 | 0,59 | 1,36E−06 | 4,26E−03 | 0,63 | 8,41E−01 | 1 | −0,03 | 4,31E−01 | 1 | 0,13 | 2,99E−01 | 1 | −0,17 | ||||||
| He-PEG3 | He-SNRPN | 5,11E−02 | 1 | 0,28 | 5,97E−04 | 1 | 0,49 | 1,87E−02 | 1 | 0,36 | 1,57E−01 | 1 | 0,21 | 1,58E−05 | 4,77E−02 | 0,63 | 4,03E−03 | 1 | 0,44 | ||||||
| SK-PEG3 | SK-LIT1 | 3,47E−04 | 1 | 0,50 | 5,76E−06 | 1,74E−02 | 0,62 | 3,03E−05 | 9,52E−02 | 0,58 | 7,50E−04 | 1 | 0,46 | 3,30E−02 | 1 | 0,30 | 3,94E−03 | 1 | 0,40 | ||||||
| Sp-IAP | Sp-L1 | 1,00E−14 | 3,03E−11 | 0,85 | 9,11E−04 | 1 | 0,46 | 1,20E−14 | 3,77E−11 | 0,85 | 1,25E−09 | 3,79E−06 | 0,76 | 5,51E−07 | 1,67E−03 | 0,67 | 5,52E−11 | 1,73E−07 | 0,81 | ||||||
| Sp-MYC | Sp-IAP | 1,92E−16 | 5,82E−13 | 0,88 | 4,13E−03 | 1 | 0,40 | 6,30E−12 | 1,97E−08 | 0,80 | 1,45E−11 | 4,37E−08 | 0,81 | 5,26E−01 | 1 | −0,10 | 3,38E−12 | 1,06E−08 | 0,83 | ||||||
| Sp-MYC | Sp-L1 | 1,14E−11 | 3,46E−08 | 0,79 | 4,68E−15 | 1,41E−11 | 0,85 | 2,79E−15 | 8,75E−12 | 0,85 | 2,06E−17 | 6,23E−14 | 0,90 | 5,13E−12 | 1,55E−08 | 0,82 | 3,07E−16 | 9,62E−13 | 0,89 | ||||||
| Sp-MYC | Sp-SNRPN | 2,36E−03 | 1 | 0,43 | 1,52E−04 | 4,59E−01 | 0,52 | 1,33E−04 | 4,18E−01 | 0,52 | 4,50E−06 | 1,36E−02 | 0,63 | 9,32E−03 | 1 | 0,38 | 3,60E−05 | 1,13E−01 | 0,59 | ||||||
| Sp-SNRPN | Sp-L1 | 8,12E−06 | 2,46E−02 | 0,60 | 3,80E−08 | 1,15E−04 | 0,69 | 1,86E−08 | 5,83E−05 | 0,71 | 3,76E−06 | 1,14E−02 | 0,62 | 1,10E−04 | 3,33E−01 | 0,53 | 1,85E−05 | 5,80E−02 | 0,60 | ||||||
Data for two separate CpG sites and their average are shown. Significant p values are in bold.